Results 161 to 170 of about 2,026 (172)

Prevalence and epidemiological associates of novel psychedelic use in the United States adult population

Journal of Psychopharmacology, 2019
Allyson Varley, James D Sexton, Peter S Hendricks   +2 more
exaly  

Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited?

International Review of Psychiatry
Daniel Villiger
exaly  

Are Psychedelic Agents Ready for Prime Time as Stand-Alone Treatments?

JAMA
openaire   +2 more sources

Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020–2021

Frontiers in Psychiatry
Robert Morlock
exaly  

Next-generation psychedelics: should new agents skip the trip?

Nature Biotechnology
openaire   +1 more source

Developing Guidelines and Competencies for the Training of Psychedelic Therapists

Journal of Humanistic Psychology, 2017
exaly  

Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use

Frontiers in Psychology
exaly  

SEROTONERGIC PSYCHEDELIC AGENT FOR TREATING SELECTIVE MUTISM

TOMLINSON LYL, SANCILIO FREDERICK, YOUNG PHILIP J, DARIANI MAGHSOUD   +3 more
openaire   +1 more source

COMBINATION COMPRISING A MONOAMINE ANTIDEPRESSANT AGENT AND A SHORT-DURATION PSYCHEDELIC AGENT

RANDS PETER, ROUTLEDGE CAROL, JAMES ELLEN, BENWAY TIFFANIE, JOEL ZELAH, ATTWOOLL VICTORIA, GOOD MEGHAN   +6 more
openaire   +1 more source

METHOD OF ADMINISTRATION OF A PARENTERAL FORMULATION COMPRISING A PSYCHEDELIC AGENT

RANDS PETER, JAMES ELLEN, BENWAY TIFFANIE, JOEL ZELAH, ROUTLEDGE CAROL, ERRITZOE DAVID, TIMMERMANN SLATER CHRISTOPHER, LAYZELL MARIE   +7 more
openaire   +1 more source